Work

Association of Tralokinumab and Adalimumab: Good Tolerance and Efficacy in a Case of Severe Atopic Dermatitis and Juvenile Idiopathic Arthritis

Year: 2025

Type: article

Abstract: ABSTRACT Atopic dermatitis is a chronic inflammatory and pruritic skin disease. The combination of tralokinumab with adalimumab in the treatment of inflammatory diseases had not yet been documented. It appears promising for treating severe atopic dermatitis in patients with juvenile idiopathic arthritis, offering significant improvement in skin symptoms as well as good clinical and biological tolerance. We report a case of severe atopic dermatitis successfully treated with tralokinumab, demonstrating good tolerance and effectiveness in a 17‐year‐old patient also on adalimumab for juvenile idiopathic arthritis.

Source: JEADV Clinical Practice

DOI: 10.1002/jvc2.70016

Authors: F. Rakotonandrasana, E. Puzenat, A. Ducournau, D. Popescu

Institutions: L'Hôpital Nord Franche-Comté, Centre Hospitalier Universitaire de Besançon

Language: English

Topic: Dermatology and Skin Diseases

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,310